Aliskiren Study of Safety and Efficacy in Senior Hypertensives

NCT01922141 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Aliskiren
DRUG: Amlodipine
DRUG: Ramipril
DRUG: Hydrochlorothiazide

Sponsor

Novartis Pharmaceuticals